Preparation of superparamagnetic iron oxide nanoparticles and its acute toxicity to mice

Academic Journal of Second Military Medical University

Volumn 28, Issue 10, 2007, Pages 1104-1108

  Wen, Ming ^a   Song, Lin ^a   Bo, Wei ^a   Li, Shao Lin ^a   Li, Bi Bo ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Nanotechnology; Superparamagnetic iron oxide; Toxicity tests

Indexed keywords

DRUG CARRIER; EOSIN; FERRIC FERROCYANIDE; FERRIC ION; HEMATOXYLIN; OXALIC ACID; SODIUM CHLORIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG SYNTHESIS; EDEMA; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; KIDNEY NECROSIS; LIVER NECROSIS; LUNG EDEMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECIPITATION; SEROLOGY; STAINING; TISSUE DEGENERATION; TISSUE NECROSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 35648944311     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Corot C, Robert P, Idee J M, et al. Recent advances in iron oxide nanocrystal technology for medical imaging[J]. Adv Drug Deliv Rev,2006,58: 1471-1504.
2. Chinese source.
3. Arbab A S, Wilson L B, Ashari P, et al. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging[J]. NMR Biomed,2005,18: 383-389.
4. Mornet S, Vasseur S, Grasset F, et al. Magnetic nanoparticle design for medical applications[J]. Progr Solid State Chem, 206, 34: 237-247.
5. Chinese source.
6. Chinese source.
7. Blasberg R G, Tjuvajev J G. Molecular-genetic imaging: current and future perspectives[J]. J Clin Invest, 2003, 111: 1620-1629.
8. Unger E C. How can superparamagnetic iron oxides be used to monitor disease and treatment[J]? Radiology, 2003, 229: 615-616.
9. Thrall J H. Nanotechnology and medicine[J]. Radiology, 2004, 230: 315-318.
10. 4 nanoparticles and their biomedical applications[J]. Biomaterials,2005,26; 729-738.
11. Bellin M F. MR contrast agents, the old and the new[J]. Eur J Radiol,2006,60: 314-323.
12. Chinese source.
13. Chinese source.
14. Daldrup-Link H E, Rudelius M, Oostendorp R A, et al. Targeting of hematopoietic progenitor cells with MR contrast agents[J]. Radiology,2003,228: 760-767.
15. Himes N, Min J Y, Lee R, et al. In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction[J]. Magn Reson Med,2004,52: 1214-1219.
16. Matuszewski L, Persigehl T, Wall A, et al. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency [J]. Radiology,2005,235: 155-161.